Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)
1 Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
2 Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands. M.Nijenhuis@knmp.nl.
3 Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands.
4 Pharmacy Boterdiep, Groningen, The Netherlands.
5 Pharmacy De Katwijkse Apotheek, Katwijk, The Netherlands.
6 Department of Public Health and Primary Care (PHEG), Leiden University Medical Centre, Leiden, The Netherlands.
7 National eHealth Living Lab (NELL), Leiden, The Netherlands.
8 Department of Clinical Pharmacy, Wilhelmina Hospital, Assen, The Netherlands.
9 Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
10 Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.
11 Department of Clinical Chemistry, St. Jansdal Hospital, Harderwijk, The Netherlands.
12 Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
13 Department of PharmacoTherapy, PharmacoEpidemiology & PharmacoEconomics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
14 Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
15 Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.